Issued Patents All Time
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12384759 | Rho kinase inhibitor ba-1049 (r) and active metabolites thereof | Kenneth M. Rosen, Matthew D. Abbinanti, Joerg Ruschel, Lisa Bond Moritz | 2025-08-12 |
| 11814361 | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof | Kenneth M. Rosen, Matthew D. Abbinanti, Joerg Ruschel, Lisa Bond Moritz | 2023-11-14 |
| 11701366 | Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors | Kenneth M. Rosen, Steven Wayne Riesinger, Lisa Bond Moritz | 2023-07-18 |
| 11324802 | C3 fusion protein and methods of making and using thereof | Ricardo BORJAS, Mark Fleming, Mei-rong Huang, Mayur JAIN, Tapan Sanghvi +4 more | 2022-05-10 |
| 11198680 | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof | Kenneth M. Rosen, Matthew D. Abbinanti, Joerg Ruschel, Lisa Bond Moritz | 2021-12-14 |
| 11098308 | Treatment of CNS injury with RNAi therapeutics | Joerg Ruschel, Emily NIEDERST, Kenneth M. Rosen | 2021-08-24 |
| 10857157 | Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors | Kenneth M. Rosen, Steven Wayne Riesinger, Lisa Bond Moritz | 2020-12-08 |
| 10537567 | Kinase inhibitors for treatment of disease | Joerg Ruschel, Matthew D. Abbinanti, Kenneth M. Rosen | 2020-01-21 |
| 10526313 | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof | Kenneth M. Rosen, Matthew D. Abbinanti, Joerg Ruschel, Lisa Bond Moritz | 2020-01-07 |
| 10149856 | Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors | Kenneth M. Rosen, Steven Wayne Riesinger, Lisa Bond Moritz | 2018-12-11 |
| 10106525 | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof | Kenneth M. Rosen, Matthew D. Abbinanti, Joerg Ruschel, Lisa Bond Moritz | 2018-10-23 |
| 9687483 | Treatment of cerebral cavernous malformations and cerebral aneurysms with Rho kinase inhibitors | Lisa M. Bond | 2017-06-27 |
| 7910554 | Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions | — | 2011-03-22 |
| 7795218 | ADP-ribosyl transferase fusion variant proteins | Jon Scott Munzer | 2010-09-14 |
| 7572913 | 4-substituted piperidine derivatives | Eryk Thouin, William Lubell, Robert A. Snow, Karine Gingras | 2009-08-11 |
| 7491692 | Methods for making and delivering Rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof | — | 2009-02-17 |
| 7442686 | Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions | Dana Lasko | 2008-10-28 |
| 7169783 | (+)-Trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesion | Maxime Lehmann | 2007-01-30 |
| 7141428 | Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof | — | 2006-11-28 |
| 6855688 | ADP-ribosyl transferase fusion proteins, pharmaceutical compositions, and methods of use | — | 2005-02-15 |